Retractable Technologies, Inc. (RVP) Short Interest Down 29.6% in October

Retractable Technologies, Inc. (NYSEAMERICAN:RVP) was the target of a large drop in short interest in October. As of October 31st, there was short interest totalling 43,030 shares, a drop of 29.6% from the October 13th total of 61,135 shares. Based on an average trading volume of 439,275 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.5% of the company’s stock are short sold.

Retractable Technologies (RVP) opened at $0.66 on Friday. Retractable Technologies has a 1 year low of $0.54 and a 1 year high of $2.59.

Retractable Technologies (NYSEAMERICAN:RVP) last posted its quarterly earnings data on Tuesday, November 14th. The company reported ($0.01) EPS for the quarter. The firm had revenue of $10.41 million during the quarter. Retractable Technologies had a negative net margin of 17.65% and a negative return on equity of 22.24%.

In other Retractable Technologies news, insider Thomas J. Shaw purchased 1,000,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 23rd. The shares were acquired at an average price of $0.57 per share, with a total value of $570,000.00. Following the transaction, the insider now owns 13,065,642 shares in the company, valued at $7,447,415.94. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In the last ninety days, insiders purchased 1,097,381 shares of company stock worth $632,053.

An institutional investor recently raised its position in Retractable Technologies stock. WealthTrust Axiom LLC raised its position in Retractable Technologies, Inc. (NYSEAMERICAN:RVP) by 6.8% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 583,062 shares of the company’s stock after buying an additional 36,898 shares during the period. WealthTrust Axiom LLC owned 1.84% of Retractable Technologies worth $740,000 as of its most recent filing with the SEC.

Separately, ValuEngine raised shares of Retractable Technologies from a “sell” rating to a “hold” rating in a research report on Monday, October 2nd.

WARNING: This report was posted by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this report on another website, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this report can be accessed at

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops and manufactures safety medical products for the healthcare industry. The Company markets VanishPoint and PatientSafe products. The VanishPoint products are designed specifically to prevent needle stick injuries and to prevent reuse. The VanishPoint safety products include tuberculin, insulin and allergy antigen VanishPoint syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL and 10mL VanishPoint syringes, and the VanishPoint autodisable syringe.

Receive News & Ratings for Retractable Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies Inc. and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply